New breast cancer drug found to boost survival rates by 30%

14 Sept 02:51 Key points summarised by AI

A new drug, ribociclib, significantly improves survival rates for younger women with the most common type of advanced breast cancer, which is fueled by estrogen.
Clinical trials demonstrated that adding ribociclib to hormone therapy increased survival rates to 70% after three and a half years, reducing mortality by 29% compared to a placebo.
This cell-cycle inhibitor offers a less toxic treatment than traditional chemotherapy by selectively targeting cancer-cell promoting enzymes, inhibiting their ability to multiply.
The treatment is particularly impactful for pre-menopausal women under 59 with advanced (stage four) disease, a group often diagnosed later with more complex cases.

Suchada: Meet the reluctant star of Thailand’s cryptic crypto drama

Yesterday 15:38 Key points summarised by AI

Thai MP Suchada Zhang Thaensap faces intense scrutiny over her husband’s substantial 1.84 billion baht wealth, with opposition lawmakers alleging connections to international scam networks.
A significant portion of her husband, Taiyang Zhang's, declared assets includes a 1.44 billion baht loan to the now-bankrupt cryptocurrency hedge fund Three Arrows Capital, which still owes him 1.34 billion baht.
Opposition MP Rangsiman Rome accused Suchada's husband of links to online scam networks and gambling sites, prompting Suchada to vehemently deny the claims, demand evidence, and file a defamation complaint.
Taiyang Zhang's background includes co-founding Ren Protocol, later sold to Alameda Research (linked to the FTX collapse), and some of his former associates have been convicted in crypto company failures.
Suchada, a former actress and first-time MP, maintains her husband's innocence, while her party leaders have distanced themselves from the allegations, deeming it a private matter.